Biovance: payments to doctors
Payments that named Biovance as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $189K
- Providers
- 322
- Transactions
- 590
- Average per transaction
- $321
The per-transaction average — $321 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 322 providers the average total is $588, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Celularity, Inc. | $157,975 | 83.4% |
| Celularity Inc. | $31,370 | 16.6% |